SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001521536-11-000247
Filing Date
2011-09-15
Accepted
2011-09-15 17:18:54
Documents
5
Period of Report
2011-06-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1100164_8ka-biozone.htm 8-K/A 32511
2 FINANCIAL STATEMENTS OF BUSINESS ACQUIRED - BIOZONE LABORATORIES, INC. q1100164_ex99-2.htm EX-99.2 417471
3 FINANCIAL STATEMENTS OF BUSINESS ACQUIRED - EQUALAN PHARMA, LLC q1100164_ex99-3.htm EX-99.3 188821
4 FINANCIAL STATEMENTS OF BUSINESS ACQUIRED - EQUACHEM, LLC q1100164_ex99-4.htm EX-99.4 148056
5 PRO FORMA FINANCIAL INFORMATION q1100164_ex99-5.htm EX-99.5 279048
  Complete submission text file 0001521536-11-000247.txt   1067093
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-146182 | Film No.: 111093536
SIC: 7389 Services-Business Services, NEC